Publicaciones en las que colabora con SARA HERNANDO REVILLA (11)

2023

  1. Extracellular vesicles released by hair follicle and adipose mesenchymal stromal cells induce comparable neuroprotective and anti-inflammatory effects in primary neuronal and microglial cultures

    Cytotherapy, Vol. 25, Núm. 10, pp. 1027-1032

  2. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 5

2022

  1. Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

2021

  1. Polycaprolactone hybrid scaffolds combining 3D printing and electrospinning to guide the osteogenic differentiation of MC3T3 preosteoblasts for bone tissue regeneration

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 30-32

2020

  1. Nanostructured lipid carriers made of Ω-3 polyunsaturated fatty acids: In vitro evaluation of emerging nanocarriers to treat neurodegenerative diseases

    Pharmaceutics, Vol. 12, Núm. 10, pp. 1-22

  2. Novel nanostructured lipid carriers based on Ω-3 polyunsaturated fatty acids and TAT peptide for neurodegenerative disease treatment

    Novel nanostructured lipid carriers based on Ω-3 polyunsaturated fatty acids and TAT peptide for neurodegenerative disease treatment

2019

  1. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

    Neurobiology of Disease, Vol. 121, pp. 252-262

2018

  1. Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 145-155

  2. The role of lipid nanoparticles and its surface modification in reaching the brain: An approach for neurodegenerative diseases treatment

    Current Drug Delivery, Vol. 15, Núm. 9, pp. 1218-1220

2017

  1. Nanotechnology based approaches for neurodegenerative disorders: Diagnosis and treatment

    Drug and Gene Delivery to the Central Nervous System for Neuroprotection: Nanotechnological Advances (Springer International Publishing), pp. 57-87

2016

  1. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

    Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285